Trial Profile
Enoxaparin - effective dosage for intensive care patients: a double-blinded, randomised clinical trial- part 2.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- 26 Feb 2010 New trial record
- 26 Feb 2010 New trial record